Skip to main content
logo
Electra Therapeutics, Inc. (ETRA)
NASDAQ: ETRA · Real-Time Price · USD
11.82
-0.85 (-6.71%)
Sep 24, 2026, 4:00 PM EDT - Market closed

Electra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Market Capitalization
742--
Market Cap Growth
---
Enterprise Value
646--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Debt / Equity Ratio
0.020.02-
Net Debt / Equity Ratio
-1.04-0.96-1.04
Net Debt / EBITDA Ratio
-1.37-
Net Debt / FCF Ratio
1.271.380.61
Quick Ratio
7.198.923.78
Current Ratio
7.379.824.63
Return on Equity (ROE)
--119.89%-
Return on Assets (ROA)
--65.13%-
Return on Capital Employed (ROCE)
-93.40%-69.00%-172.90%
SEC Filings: 10-K · 10-Q